Oncomatryx Biopharma
Nagore Andraka Rueda is a clinical operations specialist currently working at Oncomatryx Biopharma since April 2024. Prior to this role, Nagore served as a study coordinator at Instituto Murciano de Investigación Biosanitaria from November 2020 to May 2024 and held the position of project manager at BIOEF from October 2019 to October 2020. Additional experience includes being the head of the lab at Nantek from July 2019 to June 2020 and involvement in clinical trials monitoring and project management at TECNALIA Research & Innovation in 2018. Academic credentials include a Master in Clinical Trials Monitoring and Project Management from ESAME-UCM, a Molecular Biology online course from Universidad de Las Palmas de Gran Canaria, a Master in Biomedicine and Molecular Biology from Universidad del País Vasco, and a Bachelor's Degree in Biochemistry from the same institution.
This person is not in any teams
Oncomatryx Biopharma
Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment.Oncomatryx has developed precision drugs and diagnostic devices that target the tumor stroma.Oncomatryx Antibody-Drug Conjugates (ADCs) and human-derived proteins target peritumoral fibroblasts, endothelial cells and extracellular matrix that promote tumorinvasiveness, drug resistance and immunosuppression.Oncomatryx ADCs bear novel proprietary payloads and linker derivatives that render an optimal therapeutic index against pancreatic cancer in vivo. Oncomatryx OMTX705, an ADC which targets cancer-associated fibroblasts (CAFs), inhibits pancreatic tumor growth in patient-derived xenograft mice, both as single agent and in combination with chemotherapy.